FIG A4.
Comparison of the prevalence of BRCA2 mutations in stage IV KRASG12C-mutant NSCLC with and without brain metastases in the MSK-MET cohort. MSK-MET, Memorial Sloan Kettering–Metastatic Events and Tropisms; NSCLC, non–small-cell lung cancer.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.